Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CorMedix Inc. Director's Dealing 2011

Dec 16, 2011

32333_dirs_2011-12-16_73f93d90-845b-4cfc-beb0-8e521c904ab3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2011-12-15

Reporting Person: Lefkowitz James (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-12-15 Common Stock, $0.001 par value per share P 1200 $0.31 Acquired 40272 Direct